Dong-A sales to achieve 216.4 billion won in first quarter

Published: 2011-03-29 06:58:00

Updated: 2011-03-29 06:58:00

Dong-A Pharmaceutical’s first quarter sales will increase by 7.7 percent this year, while its operating profits for the period will also increase by 7.7 percent compared to the same period last year, according to Kim Na-yeon, market analysis at Woori Investment & Securities Co.

Kim said the co...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK